<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164738">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01815697</url>
  </required_header>
  <id_info>
    <org_study_id>NSFC-81070488</org_study_id>
    <nct_id>NCT01815697</nct_id>
  </id_info>
  <brief_title>The Effect of Enhanced External Counterpulsation Treatment to Lower Urinary Tract Symptoms</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if enhanced external counterpulsation treatment can
      improve lower tract symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>evaluated lower urinary tract symptoms by International Prostate Symptom Score</measure>
    <time_frame>four weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary flow rate</measure>
    <time_frame>four weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <arm_group>
    <arm_group_label>lower urinary tract symptoms</arm_group_label>
    <description>Men with lower urinary tract symptoms included for evaluating the lower urinary tract symptoms before and after the Enhanced external counterpulsation treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enhanced external counterpulsation(EECP)</intervention_name>
    <description>Enhanced external counterpulsation(EECP) is used in cardiovascular and cerebrovascular diseases，which has the ability to improve the microcirculation</description>
    <arm_group_label>lower urinary tract symptoms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men complaining lower urinary tract symptoms were enrolled
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. men over 18 years old;

          2. provide signed informed consent;

          3. existence of lower urinary tract symptoms

          4. Agree not to use any lower urinary tract symptoms treatment at least one month;

        Exclusion Criteria:

          1. a history of long drug abuse;

          2. pelvic, spine, brain trauma or surgery;

          3. endocrine, liver, lung, kidney disease, malignancies, hematological     disorders;

          4. Severe infection without effective control；

          5. lower limbs deep vein thrombosis；

          6. Large area of ​​ulcerative rash；
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 21, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Chen Sheng Fu,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Men</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
